difference in semaglutide and wegovy vs. Ozempic: Important Differences To Consider What Is The Difference Between
Description
Mounjaro is a weight loss injection manufactured by Eli Lilly that targets obesity through its dual action as both a GLP-1 and GIP agonist.

Solution Volume: 2.4 ml

PMCID: PMC7153899

Get GLP-1 Weight Loss Treatments at Cape Fear Physical Medicine and Rehab in Fayetteville, NC, for Sustainable Results and Personalized Care.
